Screening for CYP3A4 induction potential
by MDS Pharma Services
In this application note, MDS Pharma Services describes how its model for screening CYP3A4 induction, which is based on genetically engineered human cells, provides greater benefits over previous models in generating fast, high-volume and consistently reproducible data.
| Published: | 2003 |
| Format: | |
| Length: | 4 pages |
| Type: | Application Note |
| Language: | English |
.
SPONSORED REPORTS
